Unlocking drug repurposing clinical trials: resources for investigators

Drug repurposing has recently been recognized for its potential to improve the process of drug development. To facilitate the implementation of drug repurposing in clinical research, resources to support investigators in conducting Phase II repurposing trials are under development, which will be presented as part of a comprehensive platform. Innovative clinical trial designs and mechanism-based network pharmacology are also emphasized.

Content

Author and article information

Journal

Title: DrugRxiv

Publisher: REPO4EU

Publication date (Electronic preprint): 7 October 2024

Affiliations

[1 ] 3D-PharmXchange;

Author notes

[* ]Email: bridget@ 1234563d-pxc.com .

Author information

Bridget Peterson https://orcid.org/0009-0004-1063-3482

Article

DOI: 10.58647/DRUGARXIV.PR000016.v1

SO-VID: 119a0679-b6e3-4a78-be79-4511ec54e5a7

License:

This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

History

Date received : 7 October 2024

Unlocking drug repurposing clinical trials: resources for investigators

Abstract